There’s a particular kind of ambition that doesn’t announce itself loudly. It moves through back channels, private letters to Geneva missions, quiet conversations between diplomats in corridors. That’s precisely the energy surrounding the World Health Organization‘s director-general election right now — formal, careful, and carrying the weight of a global health system that has been quietly fracturing for over a year.
On April 24, WHO Director-General Dr. Tedros Adhanom Ghebreyesus sent nomination invitations to all member states, opening a six-month window — closing September 24 — for countries to put forward their candidates. The actual appointment won’t happen until the Eightieth World Health Assembly in May 2027. But the maneuvering has already started, and nowhere more quietly than in Berlin.
Germany, according to people familiar with internal government thinking, is considering nominating Helge Braun — a physician-turned-politician who served as Angela Merkel’s Chief of Staff during her final term from 2018 to 2021. He later chaired the German Bundestag’s powerful Budget Committee until 2025. The German Foreign Ministry, when asked directly, declined to confirm or deny anything. That kind of non-denial, in diplomatic circles, tends to speak for itself.
The timing of Germany’s interest is not accidental. When the United States withdrew from the WHO in January 2025 and stopped paying its dues, the organization was thrown into a financial spiral — one that eventually led to layoffs affecting roughly a quarter of its workforce. Germany, now the largest global health donor in the aftermath of that withdrawal, wants something in return. Specifically, Berlin appears to want its financial contribution reflected in the person sitting at the top of the organization’s structure. It’s a reasonable expectation, and also a politically complicated one.
On paper, Braun’s case is quite intriguing. He is neither a conventional global health figure nor a career diplomat. After receiving training as an anesthesiologist and critical care physician, he worked for years at the heart of the German government. He reportedly compared the Chancellery to an intensive care unit (ICU) during COVID-19, where urgent issues had to be resolved without the luxury of waiting. During one of the most turbulent times in recent European history, he managed the nexus of political decision-making and scientific advice. This background is important because the WHO does not currently require a ceremonial head. It requires someone who is familiar with internal institutional pressure.
However, it would be dishonest to overlook the legitimate concerns that surround Braun’s possible candidacy. Germany’s government opposed the release of COVID-19 vaccine patents at a moment when the entire Global South was watching, and Braun himself publicly defended that position. That position is significant to many WHO member nations, especially those in Africa, Asia, and Latin America. It’s a defining data point about whose interests a German candidate might ultimately serve. Winning the WHO director-general post requires broad support from member states across every region, and skepticism from the Global South could prove decisive.
There’s also the matter of name recognition. Outside Germany, Braun is largely unknown. He lost the CDU party leadership race in December 2021 — fairly heavily — to Friedrich Merz, who is now Chancellor. He was seen by party members as being too moderate and too closely associated with the Merkel establishment. It’s difficult to say if that label will follow him abroad, but it’s not a plus.
Although former Health Minister Karl Lauterbach and the lesser-known Paul Zubeil have been mentioned, it is still unclear if Germany will formally proceed with Braun or take other candidates into consideration. It is anticipated that candidates who have remained silent up to this point will start making public declarations at the World Health Assembly in May. That meeting will probably be the first clear indication of the race’s direction.
As this develops, it seems that the WHO director-general election is about more than just personnel. After a period of real trauma, the WHO is underfunded, has fewer employees, and must navigate a world where its biggest historical donor has left. This is a referendum on the kind of organization the organization wants to be. All of that will pass to the victor in May 2027. The question is whether Germany’s candidate, whoever they end up being, can convince the world that Berlin’s interests and global health interests are synonymous. Making that case is more difficult than it might seem from within the Chancellery.
